Anthony Petrone
Stock Analyst at Mizuho
(3.72)
# 686
Out of 5,182 analysts
218
Total ratings
49.7%
Success rate
7.67%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNKD MannKind | Maintains: Outperform | $10 → $8 | $2.70 | +196.30% | 1 | Apr 13, 2026 | |
| MDT Medtronic | Maintains: Outperform | $125 → $120 | $83.32 | +44.02% | 8 | Apr 13, 2026 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $85 → $95 | $84.33 | +12.65% | 9 | Apr 13, 2026 | |
| ISRG Intuitive Surgical | Maintains: Neutral | $575 → $525 | $482.22 | +8.87% | 7 | Apr 13, 2026 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $85 → $70 | $56.31 | +24.31% | 9 | Apr 13, 2026 | |
| HAE Haemonetics | Maintains: Outperform | $80 → $70 | $59.93 | +16.80% | 18 | Apr 13, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $95 → $90 | $68.83 | +30.76% | 7 | Apr 13, 2026 | |
| EW Edwards Lifesciences | Maintains: Outperform | $100 → $95 | $84.15 | +12.89% | 11 | Apr 13, 2026 | |
| EMBC Embecta | Maintains: Neutral | $14 → $12 | $9.22 | +30.15% | 4 | Apr 13, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $115 → $90 | $62.07 | +45.00% | 10 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $24 | $11.26 | +113.14% | 7 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $21 | $13.20 | +59.09% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $100 | $66.28 | +50.88% | 10 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $22 | $20.36 | +8.06% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $90 | $61.57 | +46.18% | 4 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $3.43 | +191.55% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $72 | $64.20 | +12.15% | 10 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $120 | $88.91 | +34.97% | 4 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $100 | $64.42 | +55.23% | 16 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $39.25 | +1.91% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $110 → $100 | $75.80 | +31.93% | 11 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $300 | $219.85 | +36.46% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $135 | $136.56 | -1.14% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $140 → $135 | $91.13 | +48.14% | 6 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $18 | $25.67 | -29.88% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $121.48 | +44.06% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $7.05 | +467.38% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $61.45 | -5.61% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $113.45 | -40.94% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $91.26 | +91.76% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $12.53 | +99.52% | 3 | May 13, 2020 |
MannKind
Apr 13, 2026
Maintains: Outperform
Price Target: $10 → $8
Current: $2.70
Upside: +196.30%
Medtronic
Apr 13, 2026
Maintains: Outperform
Price Target: $125 → $120
Current: $83.32
Upside: +44.02%
Lantheus Holdings
Apr 13, 2026
Maintains: Outperform
Price Target: $85 → $95
Current: $84.33
Upside: +12.65%
Intuitive Surgical
Apr 13, 2026
Maintains: Neutral
Price Target: $575 → $525
Current: $482.22
Upside: +8.87%
Inspire Medical Systems
Apr 13, 2026
Maintains: Outperform
Price Target: $85 → $70
Current: $56.31
Upside: +24.31%
Haemonetics
Apr 13, 2026
Maintains: Outperform
Price Target: $80 → $70
Current: $59.93
Upside: +16.80%
GE HealthCare Technologies
Apr 13, 2026
Maintains: Outperform
Price Target: $95 → $90
Current: $68.83
Upside: +30.76%
Edwards Lifesciences
Apr 13, 2026
Maintains: Outperform
Price Target: $100 → $95
Current: $84.15
Upside: +12.89%
Embecta
Apr 13, 2026
Maintains: Neutral
Price Target: $14 → $12
Current: $9.22
Upside: +30.15%
Boston Scientific
Apr 13, 2026
Maintains: Outperform
Price Target: $115 → $90
Current: $62.07
Upside: +45.00%
Apr 13, 2026
Maintains: Outperform
Price Target: $30 → $24
Current: $11.26
Upside: +113.14%
Mar 31, 2026
Initiates: Outperform
Price Target: $21
Current: $13.20
Upside: +59.09%
Feb 25, 2026
Maintains: Outperform
Price Target: $90 → $100
Current: $66.28
Upside: +50.88%
Feb 20, 2026
Maintains: Neutral
Price Target: $21 → $22
Current: $20.36
Upside: +8.06%
Feb 13, 2026
Maintains: Outperform
Price Target: $78 → $90
Current: $61.57
Upside: +46.18%
Dec 17, 2025
Maintains: Outperform
Price Target: $12 → $10
Current: $3.43
Upside: +191.55%
Dec 17, 2025
Maintains: Outperform
Price Target: $70 → $72
Current: $64.20
Upside: +12.15%
Dec 17, 2025
Maintains: Outperform
Price Target: $100 → $120
Current: $88.91
Upside: +34.97%
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $100
Current: $64.42
Upside: +55.23%
Dec 1, 2025
Initiates: Outperform
Price Target: $40
Current: $39.25
Upside: +1.91%
Nov 11, 2025
Maintains: Outperform
Price Target: $110 → $100
Current: $75.80
Upside: +31.93%
Oct 31, 2025
Maintains: Outperform
Price Target: $310 → $300
Current: $219.85
Upside: +36.46%
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $136.56
Upside: -1.14%
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $91.13
Upside: +48.14%
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $25.67
Upside: -29.88%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $121.48
Upside: +44.06%
Apr 10, 2025
Initiates: Outperform
Price Target: $40
Current: $7.05
Upside: +467.38%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $61.45
Upside: -5.61%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $113.45
Upside: -40.94%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $91.26
Upside: +91.76%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $12.53
Upside: +99.52%